HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹70 Cr | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr |
What is the latest Consolidated Net Profit of HIKAL ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹78 Cr |
| Mar2023 | ₹160 Cr |
| Mar2022 | ₹133 Cr |
| Mar2021 | ₹84 Cr |
How is Consolidated Net Profit of HIKAL Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | -11.20 | |
| Mar2024 | ₹78 Cr | -51.16 | |
| Mar2023 | ₹160 Cr | 20.55 | |
| Mar2022 | ₹133 Cr | 57.68 | |
| Mar2021 | ₹84 Cr | - | |
Compare Consolidated Net Profit of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,536.9 Cr | 6.8% | -3.7% | -39.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 6.8% |
-3.7% |
-39.8% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses